Twelve-Part Webinar Series


When: 

Thursday, February 29th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, March 12th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, March 26th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, April 9th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, April 23rd, 2024 from 1pm - 3pm ET
Tuesday, May 14th, 2024 from 1pm - 3pm ET
Tuesday, May 28th, 2024 from 1pm - 3pm ET
Tuesday, June 18th, 2024 from 1pm - 3pm ET
Tuesday, June 25th, 2024 from 1pm - 3pm ET
Tuesday, July 9th, 2024 from 1pm - 3pm ET
Tuesday, July 16th, 2024 from 1pm - 3pm ET
Tuesday, July 30th, 2024 from 1pm - 3pm ET - BONUS WEBINAR!

The Center for Forensic Science Research and Education, with support from the Centers for Disease Control and Prevention (CDC) and the National Network of Public Health Institutes (NNPHI) is pleased to offer a thought-provoking twelve-part series entitled, “The Role of Comprehensive Medicolegal Death Investigation as Part of a Public Health Improvement Strategy”.  

This twelve-part series will feature presentations from forensic pathology, forensic toxicology, and medical toxicology experts; followed by panel discussions and interactive Q&A sessions on emerging topics and challenges in drug toxicity in death in today’s challenging illicit drug environment. The series will involve a multitude of topics relating to drug and substance poisoning deaths that pose complexities and challenges in ensuring we are collecting accurate drug death certification data. Attendees will also gain an understanding of how forensic pathologists use autopsy findings and other evidence to determine the cause and manner of death in drug-related cases.

Each webinar in this series will explore the challenges and limitations of drug death certification, including issues related to the interpretation of toxicological results, the identification of drug-related deaths, and the potential for false-positive or false-negative results. We will also be exploring the emerging topics in drug death certification, such as the use of new psychoactive substances and the impact of the opioid epidemic on drug death rates.

The content, expert presenters, and presentation dates for the series include:

Webinar 1 - The Intersection of Forensic Pathology and Public Health: Improving Outcomes with Applied Forensic Epidemiology


WHEN:
February 29, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Abigail Grande, Western Michigan University Homer Stryeker M.D. School of Medicine, Michigan
  • Dr. Sarah Lathrop, University of New Mexico School of Medicine, New Mexico
  • Megan Broekemeier, Utah Office of the Medical Examiner, Utah
  • Dr. Michael Staley, Utah Office of the Medical Examiner, Utah

Webinar 2 - Fentanyl, Opioid and Polydrug Deaths in Infants and Children


WHEN:
March 12, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Robert Middleberg, Forensic Toxicologist at NMS Labs in Horsham, Pennsylvania
  • Dr. Katrina Monday, Onondaga County Medical Examiner's Office, New York
  • Dr. Julie Gaither, Yale School of Medicine, Connecticut 

Webinar 3 - The Forensic Autopsy as the Practice of Medicine – The Public Health Value of Comprehensive Medicolegal Death Investigation


WHEN:
March 26, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Deland Weyrauch, Montana State Medical Examiner's Office, Montana
  • Dr. Reade Quinton, Southern Minnesota Regional  Medical Examiner's Office and the Mayo Clinic, Minnesota
  • Dr. John Walsh, Armed Forces Military Examiner System, USA

Webinar 4 - NPS Discovery Updates and Trend Reports for Emerging Drugs in 2024


WHEN:
April 9, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Alex Krotulski, Center for Forensic Science Research and Education in Horsham, Pennsylvania
  • Dr. Lorenzo Gitto, Cook County Medical Examiners Office, Illinois
  • Donna Papsun, NMS Labs in Horsham, Pennsylvania

Webinar 5 - Veterinary Drugs and other Toxic Adulterants in the US Drug Supply


WHEN:
April 23, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Ed Sisco, National Institute Standards and Technology, Maryland
  • Dr. Lewis Nelson, Rutgers University School of Medicine in Camden, New Jersey
  • Dr. Barry Logan, Forensic Toxicologist and Executive Director of the CFSRE, Pennsylvania

Webinar 6 - The ToxIC Registry and Initiatives in the Medical Toxicology Community to Understand Issues in Drug Overdose, Morbidity, and Mortality


WHEN:
May 14, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Alex Manini, Icahn School of Medicine at Mount Sinai, New York
  • Dr. Kim Aldy, American College of Medical Toxicology, Arizona
  • Sarah Walton, Center for Forensic Science Research and Education in Horsham, Pennsylvania

 

Webinar 7 - The Value of Prescription Drug Monitoring Programs in the United States, with Discussion of Access and Utility Challenges for Medicolegal Death Investigators


WHEN:
May 28, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Wes Sargent, Centers for Disease Control and Prevention, Georgia
  • Erin Worrell, Office of the Chief Medical Examiner in Denver, Colorado
  • Dr. Kimberly Molina, Cheif Medical Examiner in Bexar County, Texas

 

Webinar 8 - Best Practices in Certification of Drug-Caused and Drug-Related Deaths: Drugs on Contributory Causes or Incidental Findings?


WHEN:
june 18, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Laura Labay, NMS Labs in Horsham, Pennsylvania
  • Dr. Jim Gill, Chief Medical Examiner for the State of Connecticut
  • Dr. Greg Davis, Chief Medical Examiner for Jefferson County, Alabama

 

Webinar 9 - SUDORS: Using Data from the Medicolegal Death Investigation Community to Inform Drug Overdose Prevention and Response


WHEN:
june 25, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Amanda Dinwiddie, Centers for Disease Control and Prevention, Georgia
  • Adam Ernst, Department of Health and Human Services, Nevada
  • Matthew, Kappel, Southern Nevada Health District, Nevada


Webinar 10 - Components of Counterfeit Pills: Death Investigation, Toxicology Report, Autopsy Suite to Preventative Public Health Responses


WHEN:
july 9, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Julie O'Donnell, Centers for Disease Control and Prevention, Georgia
  • Dr. Michelle Aurilius, Chief Medical Examiner for the State of North Carolina
  • Laura Friederich, Office of the Chief Medical Examiner, North Carolina
  • Sarah Shuda, Center for Forensic Science Research and Education in Horsham, Pennsylvania

Webinar 11 - Challenges in Investigation of Drug-Related Deaths in Small / Rural Jurisdictions


WHEN:
july 16, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Tom Gilson, Chief Medical Examiner of Cuyahoga County, Ohio
  • Dr. John Lucas, Office of the Chief Medical Examiner San Diego, California
  • Dan Anderson, NMS Labs in Horsham, Pennsylvania
  • Dr. Jennie Duval, Office of the Chief Medical Examiner, New Hampshire

Webinar 12 - Poison Centers and NPDS: Safeguarding Public Health with Data and Expertise


WHEN:
july 30, 2024 FROM 1 PM - 3 PM ET

PRESENTERS:

  • Dr. Jeanna Marraffa, Upstate New York Poison Center, New York
  • Dr. Michael Yeh, Centers for Disease Control and Prevention, Georgia
  • Dr. Alvin Bronstein, Hawaii Department of Health, Hawaii

 

*The webinar series content has been reviewed by the ABFT and ABC, and determined to be acceptable for submission to the ABFT or ABC for continuing education credit.  

*The following statements apply to all live/virtual sessions*
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and The Center for Forensic Science Research and Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Funding for this training was made possible by a cooperative agreement between the National Network of Public Health Institutes (NNPHI) and the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (NOFO OT18-1802, titled Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health). The views expressed in training materials or by speakers and moderators in presentations do not necessarily reflect the official policies of HHS, CDC, or NNPHI, and the mention of trade names, commercial practices, or organizations does not imply endorsement by the United States government.


REGISTER